News & Perspective

May 14, 2002

May 14, 2002

CDC to hear from the public on smallpox vaccination issues

Federal health authorities provide opportunities in the next month for input as they revise the current policy regarding vaccination of the general population.

Aug 25, 2005

Aug 25, 2005

Europe sees little risk of avian flu from wild birds

(CIDRAP News) – European veterinary experts who met in Brussels today concluded there is little immediate risk that wild birds will spread avian influenza from Russia into Europe.

Oct 28, 2005

Oct 28, 2005

Chiron wins H5N1 vaccine contract; WHO says virus is changing

(CIDRAP News) – The US government has awarded Chiron Corp. a $62.5 million contract to make a vaccine for H5N1 avian influenza as part of efforts to prepare for a possible human flu pandemic.

Mar 01, 2006

Mar 01, 2006

HHS orders drugs to treat 14 million in flu pandemic

(CIDRAP News) – US health officials announced today they have ordered more than 14 million treatment courses of two antiviral drugs to add to the 5.5 million courses already bought in preparation for a possible influenza pandemic.

Apr 18, 2007

Apr 18, 2007

Danish firm expects to sell smallpox vaccine to US

(CIDRAP News) – Bavarian Nordic, a Danish company, announced this week that the US government plans to buy 20 million doses of the company's Imvamune smallpox vaccine, but a US official said no decision has been made yet.

Imvamune is Bavarian's version of modified vaccinia Ankara (MVA), which is considered safer than the conventional smallpox vaccine, particularly for people with weakened immune systems, pregnant women, and children.

Jun 05, 2007

Jun 05, 2007

Danish firm wins US contract for new smallpox vaccine

(CIDRAP News) – US officials have announced the award of a $500 million contract to Bavarian Nordic A/S, a Danish firm, for 20 million doses of a smallpox vaccine that's expected to be safe for people with weakened immune systems.

Sep 04, 2007

Sep 04, 2007

FDA approves Acambis smallpox vaccine

(CIDRAP News) – A second-generation smallpox vaccine made by the British biotechnology company Acambis plc and stockpiled by the US government as protection against bioterrorist attacks has been approved by the US Food and Drug Administration (FDA).

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Feb 08, 2008

Feb 08, 2008

US military switching to new smallpox vaccine

Editor's note: This story was revised Feb 11 to include some additional information provided by the Department of Defense.

(CIDRAP News) – After vaccinating more than a million personnel with the old-fashioned type of smallpox vaccine grown on the skin of calves, the US military is about to switch to a second-generation vaccine that's grown in laboratory cell cultures.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»